E-Book | December 21, 2019

Outsourcing Trends For Cell & Gene Therapy

Source: Outsourced Pharma
19_12_OP_OutsourcingCellGeneTherapyEbook_450x300

The cell and gene therapy sector’s focus on outsourcing is a major area of on-going concern due to the shortage of suitable manufacturing facilities and qualified outsourcing staff. As biopharma companies take advantage of the extended expertise of outsourcing, others have opted to build their own manufacturing facilities or perform at least a portion of the manufacturing process in house. Indeed, the cell therapy, gene therapy, and gene-modified cell therapy spaces have and will continue to evolve rapidly, as will their manufacturing processes. This collection of articles weighs the economic benefits of outsourcing (i.e. productivity, efficiency, time-to-market, and quality gains) as well as best practices for selecting an outsourcing partner. Here you’ll find information about the current limitations associated with a complicated manufacturing process as well as existing and promising opportunities and developments needed to outsource most — if not all components — of the value chain.

VIEW THE E-BOOK!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: